Oral tolerance: Elucidation of mechanisms and application to treatment of autoimmune diseases

被引:0
作者
Fowler, E [1 ]
Weiner, HL [1 ]
机构
[1] BRIGHAM & WOMENS HOSP, CTR NEUROL DIS, BOSTON, MA 02115 USA
关键词
oral tolerance; hyporesponsiveness; oral administration of protein; antigen; regulatory T cells; cytokines; inflammation; autoimmune diseases;
D O I
10.1002/(SICI)1097-0282(1997)43:4<323::AID-BIP5>3.0.CO;2-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oral tolerance is the phenomenon of systemic, antigen specific, immunological hyporesponsiveness that results from oral administration of a protein. The mechanism by which tolerance is generated depends on the amount of antigen administered; low doses favor induction of regulatory T cells while higher doses favor clonal deletion and anergy. The regulatory T cells induced by low doses of oral antigen are triggered by the same antigen to secrete cytokines that suppress, in an antigen nonspecific manner, inflammation in the microenvironment where the triggering antigen is located. This makes possible the targeted delivery of antiinflammatory cytokines to a specific tissue without the requirement for identifying the antigen causing the inflammation. This attribute makes active suppression an attractive mechanism Sor developing therapies for autoimmune diseases. Orally administered autoantigens have been shown to suppress a wide variety of experimental autoimmune diseases and have recently been applied to the treatment of human autoimmune diseases with promising early results. (C) 1997 John Wiley & Sons, Inc.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 100 条
[1]  
AlSabbagh AM, 1996, J NEUROSCI RES, V45, P424, DOI 10.1002/(SICI)1097-4547(19960815)45:4<424::AID-JNR11>3.0.CO
[2]  
2-0
[3]   A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis [J].
Barnett, ML ;
Combitchi, D ;
Trentham, DE .
ARTHRITIS AND RHEUMATISM, 1996, 39 (04) :623-628
[4]   ORAL-ADMINISTRATION OF HUMAN INSULIN TO NOD MICE GENERATES CD4(+) T-CELLS THAT SUPPRESS ADOPTIVE TRANSFER OF DIABETES [J].
BERGEROT, I ;
FABIEN, N ;
MAGUER, V ;
THIVOLET, C .
JOURNAL OF AUTOIMMUNITY, 1994, 7 (05) :655-663
[5]  
BRANDTZAEG P, 1989, CURR TOP MICROBIOL, V146, P13
[6]   SUPPRESSION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY ORAL-ADMINISTRATION OF MYELIN ANTIGENS .4. SUPPRESSION OF CHRONIC RELAPSING DISEASE IN THE LEWIS RAT AND STRAIN-13 GUINEA-PIG [J].
BROD, SA ;
ALSABBAGH, A ;
SOBEL, RA ;
HAFLER, DA ;
WEINER, HL .
ANNALS OF NEUROLOGY, 1991, 29 (06) :615-622
[7]  
BRUCE MG, 1986, IMMUNOLOGY, V59, P295
[8]  
CHASE MW, 1946, P SOC EXP BIOL MED, V61, P257
[9]  
CHEN Y, 1996, UNPUB
[10]   REGULATORY T-CELL CLONES INDUCED BY ORAL TOLERANCE - SUPPRESSION OF AUTOIMMUNE ENCEPHALOMYELITIS [J].
CHEN, YH ;
KUCHROO, VK ;
INOBE, J ;
HAFLER, DA ;
WEINER, HL .
SCIENCE, 1994, 265 (5176) :1237-1240